Member Info for VertizeaSun

delete don't

There is no bloody delay. Every CEO I've known (an awful lot) would think the first couple of weeks of January as "early January" and conversely the last couple of weeks of January as "late January".

It means you don't bloody well don't know the exact date until it happens!

Indeed. We know he's been to at least one previous JP Morgan Bio-Tech. Was the data release screwed over by box-ticking? Nothing would surprise me with the UK's insane level of box ticking.

All I can find is Tom re-tweeting this on Jan 6:

RAH
@RAH00084
Jan 4
Thanks to EnergyShares on lse.

Affyxell presenting at the JP Morgan biotech showcase - 9th Jan 3:30 PM.
This is worth a lot more than the market currently assumes (I.e. nothing!)
#AVCT really is shaping up quite nicely.
https://twitter.com/RAH00084/status/1610565551922855938

Very good Hoofer

But do the "expanded access" regulations apply in the UK. I doubt it. It is a US web site.

Thanks Muck and BuenaVista. Great info.

I guess it's safe to assume AS will be in San Fransisco on Monday....meeting his South Korean colleagues.

A reminder that a Data Update from Avacta will provide more than just Safety Data as per the heading in clinicaltrials.gov:

"A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours"

https://www.clinicaltrials.gov/ct2/show/NCT04969835?term=AVA+6000&draw=2&rank=1

and also states in the official title:

"Official Title: A Phase 1, Open Label, Dose-Escalation and Expansion Study to Evaluate the Safety, Pharmacokinetics and Initial Therapeutic Activity of AVA6000,"

I'm hoping we'll be told in plain English that AVA6000 is helping save lives. And a happy New Year to all readers.

Gordon Brown has typically forgotten that the alternative to Boris Johnson was Jeremy Corbyn....remember him?

TMAC not only works but is a maturing science. POINT Bio two days confirmed it will receive $260m this week from Lantheus Holdings with another $250m due on FDA approval for a license for POINT's TMAC-FAP technology.

meow

Direct from AS......"and you get NO damage to the healthy tissues"

3m 45s

A couple of them are already on Avacta's board......hopefully helping with a Nasdaq application.

It's probably Touk.

I imagine they would add a small premium ........ 10%...?

And the Science Day date? My guess is don't be surprised to see a pre-Christmas RNS announcing a day in January.

Judging by the rodent intestine photograph doing the rounds I'd say it's a possibility.

MrRipley.....you're wrong and you're wasting your breath. AS promised on the 10th January:

""We believe COVID-19 testing remains a long-term commercial opportunity. We will therefore use the robustness of the Affimer® platform, and what we have learned about the SARS-CoV-2 virus, to generate THE NEXT GENERATION antigen test that will be as resilient as possible to any future mutations."

And the purchase of Launch nailed it.

Showing volume traded yesterday as 59.8 million. Typo?